THC Therapeutics Secures Acquisition, Gains Vertically Integrated Cannabis Portfolio with The Headquarters Group
The acquisition is anticipated to provide a foothold in two states and allow for further expansion in additional locations.
Image | adobe.stock/izzuan
In a June 24, 2025, press release, US public company THC Therapeutics (THCT), Inc. announced the full acquisition of The Headquarters Group, Inc. (THG), an Oregon-based holding company with a portfolio of cannabis companies across two states and a combined 2024 revenue of approximately $4.8 million (1). The transaction was valued at $11 million.
“This collaboration of deep expertise from world class cannabis operations management with over 60 years of combined experience will allow us to maximize efficiencies and generate significant revenue for THCT,” stated Scott Cox, CEO of THC Therapeutics Inc., in the press release. “The combined Company will serve as a vertically integrated foundation in the Company’s focused roll-up strategy to acquire industry leading cannabis companies in the cultivation, manufacturing, distribution and nutrients segments within the regulated cannabis industry.”
THCT has been in the industry since 2001, the press release stated. Both THCT and THG managers will operate and manage the combined companies.
“The market is in a great place right now,” added Richard Rowe, CEO of THG. “The cannabis market itself is growing, while the industry that supports that market is in a strong consolidation phase. This is a good place to be for a successful business with proven systems and access to capital. We believe now is a great time to partner with someone like Scott and with a platform like THCT. Investment money has driven the market since its inception. Those who could spend the most money the fastest, were often, temporarily, perceived by the market to be the winners. Now the Era of Efficiency has come, moving forward efficiency, more and more, is going to drive values and returns.”
Companies included in THG’s portfolio include cultivation and extraction company Jefferson Soul; two real estate holding companies Shasta Properties Management and Blue Sky Investments; plus three nutrient and fertilizer companies Kalix, NPK Industries, and Harvest Food for Life.
“This isn’t a starting point, it’s a launching pad and a breakthrough transaction that delivers on our team’s commitment to building out a fully integrated vertical cannabis platform,” Cox also stated. “It immediately unites several segment leaders into a powerful and flexible player in the legal cannabis market.”
“This kicks off our strategy of acquiring industry leaders in our focused verticals that can grow and expand with the management expertise and the capital we can inject as a public company,” Cox concluded. “The acquisition gives THCT a strong foundation for rapid growth and expansion within the cannabis markets as we continue to build a world-class portfolio of assets within the cannabis sectors.”
Reference
- THC Therapeutics, Inc. THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies https://www.globenewswire.com/news-release/2025/06/24/3104222/0/en/THC-Therapeutics-Inc-Announces-Acquisition-of-Oregon-and-California-Consortium-of-Cannabis-Companies.html (accessed Jun 25, 2025).
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
